SMPR:一种结构增强的多模式药物 - - 疾病预测模型,用于药物重新定位和冷启动
Xin Dong1,2,3, Rui Miao4, Suyan Zhang5
1Faculty of Innovation Engineering, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macao, 999078, China.
Journal of cheminformatics
|October 15, 2025
概括
本研究介绍了用于药物重新定位的结构增强多模式关系预测 (SMRP) 模型. SMRP有效地预测了新的药物疾病关系,并利用结构信息解决了使用新药数据的挑战.
科学领域:
- 计算机化药物发现.
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 药物重新定位加速治疗发展,但受现有数据和药物结构信息未充分利用的限制.
- 现有的模型往往会与现有技术扎.
- 寒冷的开始开始.
- 这是一个很大的问题,特别是对于缺乏广泛数据的新药.
研究的目的:
- 提出一种新的结构增强多式联络预测 (SMRP) 模型,以改进药物疾病关系预测.
- 利用药物结构信息 (SMILES) 和多式联络数据来提高预测准确度.
- 开发一种实用的解决方案,用于药物冷启动问题在重新定位.
主要方法:
- 使用MOL2VEC从SMILES结构生成药物嵌入式表示.
- 使用异质网络图表神经网络来学习疾病嵌入式表示.
- 构建了一个药物-疾病关系矩阵,并根据结构相似性开发了一个冷启动接口.
主要成果:
- 在药物重新定位方面取得了高性能,AUC为99%,ACUPR为61%.
- 证明了强大的冷启动能力,AUC为80%,召回超过70%.
- 案例分析证实了SMRP模型的实际价值和结构性改进.
结论:
- 通过整合结构信息和解决冷启动问题,SMRP模型在药物重新定位方面取得了重大进展.
- 该模型的用户友好界面和本地部署增强了其对研究人员的实际应用性.
- SMRP对加速发现现有药物和新药物的新疗法应用具有前景.
相关概念视频
Drug Discovery: Overview
11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Pharmacokinetic Models: Comparison and Selection Criterion
334
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
334
Multicompartment Models: Overview
498
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
498
Pharmacokinetic Models: Overview
1.9K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.9K
Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K


